Brief: Cerevel Therapeutics Expects To Report That It Had About $758 Mln In Cash, Cash Equivalents And Marketable Securities As Of Sept 30, 2023
Oct 11 (Reuters) - Cerevel Therapeutics Holdings Inc
CERE.O :
* CEREVEL THERAPEUTICS - EXPECTS TO REPORT THAT IT HAD ABOUT
$758
MILLION IN CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES AS
OF SEPT 30, 2023
Further company coverage: CERE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cerevel Therapeutics Holdings
See all newsBrief: Abbvie Reaffirms FY Adj Diluted EPS Guidance Range $10.71-$10.91
Cerevel Therapeutics Holdings Inc expected to post a loss of 61 cents a share - Earnings Preview
Cerevel Therapeutics Holdings Inc expected to post a loss of 62 cents a share - Earnings Preview
Cerevel Therapeutics Holdings Inc expected to post a loss of 61 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Ally Financial, Zscaler, Las Vegas Sands